BeOne Medicines Ltd.SSE: 688235

Announcement on Voluntary Disclosure of Progress in Obtaining Positive Registration of Baize'an (Tislelizumab Injection) in Europe and America

· Issued by BeOne Medicines Ltd. via Shanghai Stock Exchange

Filed with SSE ·


Announcement on Voluntary Disclosure of Progress in Obtaining Positive Registration of Baize'an (Tislelizumab Injection) in Europe and America

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

BeOne Medicines Ltd. on 6ix

Later from BeOne Medicines

All BeOne Medicines news releases